PASELLO, GIULIA

PASELLO, GIULIA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 130 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts) 2021 Dal Maso, A.Ferro, A.Pretelli, G.Frega, S.Menis, J.Pasello, G.Guarneri, V.Conte, P. F. + JOURNAL OF THORACIC ONCOLOGY - -
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI) 2020 Dal Maso, A.Ferro, A.Lorenzi, M.Scattolin, D.Del Conte, A.Frega, S.Indraccolo, S.Calabrese, F.Guarneri, V.Conte, P. F.Pasello, G. + ANNALS OF ONCOLOGY - -
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 2021 Lorenzi, M.Dal Maso, A.Ferro, A.Scattolin, D.Indraccolo, S.Frega, S.Menis, J.Guarneri, V.Conte, P. F.Pasello, G. + JOURNAL OF THORACIC ONCOLOGY - -
166P: Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series 2016 Pasello, GFREGA, STEFANOIndraccolo, SFASSAN, MATTEOCONTE, PIERFRANCOCALABRESE, FIORELLA + JOURNAL OF THORACIC ONCOLOGY - -
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 2019 Evangelista L.Cuppari L.Menis J.Frega S.Pasello G. + NUCLEAR MEDICINE COMMUNICATIONS - -
28P Different genetic profiling in lung adenocarcinoma of smokers with and without chronic obstructive pulmonary disease (COPD): An exploratory analysis by next generation sequencing (NGS) 2016 SCHIAVON, MARCOLUNARDI, FRANCESCAPASELLO, GIULIACONTE, PIERFRANCOREA, FEDERICOINDRACCOLO, STEFANOCALABRESE, FIORELLA + JOURNAL OF THORACIC ONCOLOGY - -
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 2021 Dal Maso, A.Zulato, E.Fassan, M.Pasello, G.Guarneri, V.Calabrese, F.Rea, F.Indraccolo, S.Conte, P. F. + JOURNAL OF THORACIC ONCOLOGY - -
77P Glycolytic marker monocarboxylate transporter 4 (MCT4) and outcome to bevacizumab (bev): An exploratory analysis in advanced non-small cell lung cancer (A-NSCLC) 2016 CALABRESE, FIORELLAPasello, GConte, P. F + JOURNAL OF THORACIC ONCOLOGY - -
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry 2022 Giulia Pasello + JOURNAL OF THORACIC ONCOLOGY - -
A multi-center, real-life experience on liquid biopsy practice for EGFR testing in non-small cell lung cancer (NSCLC) patients 2020 Pasello G.Nardo G.Scquizzato E.Miorin M.Giovanis P.Corvaja C.Indraccolo S. + DIAGNOSTICS - -
A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case report. 2010 Pasello GREA, FEDERICO + JOURNAL OF THORACIC DISEASE - -
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 2022 Pasello, Giulia + FUTURE ONCOLOGY - -
A triple rare E709K and L833V/H835L EGFR mutation responsive to an irreversible pan-HER inhibitor: A case report of lung adenocarcinoma treated with afatinib 2016 FREGA, STEFANOCONTE, PIERFRANCOFASSAN, MATTEOPOLO, VALENTINAPASELLO, GIULIA JOURNAL OF THORACIC ONCOLOGY - -
An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma 2013 Pasello G. + CANCER TREATMENT REVIEWS - -
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) 2020 Pasello G.Chella A.Grilli G.Mandruzzato M.Grossi F.Ardizzoni A. + THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - -
Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature 2016 Russo, IrenePasello, GiuliaALAIBAC, MAURO SALVATORE ALESSANDRO + EXPERIMENTAL AND THERAPEUTIC MEDICINE - -
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 2018 FABBRI COLABICH, ALESSANDRAFranceschini, DavidePasello, GiuliaSchiavon, MarcoDei Tos, Angelo PaoloRea, FedericoCalabrese, Fiorella + CANCER TREATMENT REVIEWS - -
Changes in pulmonary function tests predict radiological response to chemotherapy in malignant pleural mesothelioma. 2013 MARULLI, GIUSEPPEPERISSINOTTO, EGLEPasello GREA, FEDERICO + EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY - -
Circulating biomarkers and risk of immune-related adverse events (irAEs) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and metastatic melanoma (mMel) 2019 Dal Maso, A.Piccin, L.Pasello, G.Guarneri, V.Conte, P. F. + ANNALS OF ONCOLOGY - -
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC) 2022 Pasello, GiuliaFabricio, Aline Sueli CoelhoDel Bianco, PaolaSalizzato, ValentinaPiccin, LuisaBenetti, BeatriceGuarneri, ValentinaDe Salvo, Gian LucaChiarion-Sileni, Vanna + JOURNAL OF CLINICAL ONCOLOGY - -